Skip to main content
. 2020 May 29;8:244. doi: 10.3389/fpubh.2020.00244

Table 3.

Laboratory results of critical COVID-19 patients.

Laboratory index Patients (n = 114)
Blood routine (Units; normal range)
Leucocytes (× 109 per L; 3.5–9.5) 5.15 (2.11)
Above 4.40%
Below 15.80%
Neutrophils granulocyte (%; 50–70) 60.20 (12.78)
Above 21.05%
Below 23.68%
Lymphocytes (× 109 per L; 1.1–3.2) 1.52 (0.99)
Above 0.88%
Below 24.56%
Platelets (× 109 per L; 125.0–350.0) 134.38 (15.97)
Above 6.14%
Below 21.05%
Hemoglobin (g/L; 130.0–175.0) 188.25 (88.03)
Below 39.47%
Cluster of differentiation 4 (per μl; 500–1,600) 436.56 (236.53)
Below 62.50%
Blood biochemistry
Albumin (g/L; 40.0–55.0) 41.52 (4.23)
Below 30.70%
ALT (U/L; 9.0–50.0) 29.99 (29.39)
Above 13.16%
Below 3.51%
AST (U/L; 15.0–40.0) 29.39 (21.46)
Above 12.28%
Below 3.51%
Total bilirubin (μmol/L; 0.0–21.0) 15.71 (10.09)
Above 20.18%
BUN (mmol/L; 3.6–9.5) 3.89 (1.25)
Below 45.61%
Serum creatinine (μmol/L; 57.0–111.0) 69.76 (20.09)
Below 27.19%
Creatine kinase (U/L; 50.0–310.0) 111.46 (169.36)
Above 5.36%
Below 27.68%
Infection-related biomarkers
Procalcitonin (ng/mL; 0.0–5.0) 0.06 (0.12)
Erythrocyte sedimentation rate (mm/h; 0.0–15.0) 38.37 (25.36)
Above 76.54%
CRP (mg/L; 0.0–5.0) 20.08 (29.38)
Above 62.86%
Myocardial injury markers
Creatine kinase (U/L; 50.0–310.0) 111.46 (169.36)
Above 5.36%
Below 27.68%
Creatine kinase isoenzymes, CK-MB (U/L; 0–18) 11.25 (9.85)
Above 7.14%
Pro-brain natriuretic peptide (pg/mL; normal range <100) 837.51 (1580.18)
Above 66.67%
Troponin (μg/L; <0.2) 9.88 (5.66)
Above 100.00%
Blood gas analysis
pH (7.35–7.45) 7.44 (0.07)
Above 32.00%
Below 68.00%
PO2 (10.64–13.3 kPa or 80–100 mmHg) 81.32 (23.14)
Above 20.00%
Below 56.00%
PCO2 (4.65–5.98 kPa or 35–45 mmHg) 42.32 (13.02)
Above 28.00%
Below 26.00%
Fraction of inspiration O2, FiO2 36.92 (15.97)
PO2/FiO2 262.56 (109.93)
>200 60.00%